Extended Data Table 6.

Number of anti-CD19 CAR T cells in blood over time by double- or triple-hit status according to a central laboratory

AUC_0–28 is defined as the AUC in a plot of number of CAR T cells in blood against scheduled visit from day 0–28. Peak is defined as the maximum number of CAR T cells in blood measured after infusion. Time to peak is defined as the number of days from axicabtagene ciloleucel infusion to the date when the number of CAR T cells in blood first reached the maximum post-baseline level. Patients included are all treated patients, including two in nondouble- or triple-hit with IPI score <3 and eight in double- or triple-hit status not done. CAR, chimeric antigen receptor; IPI, International Prognostic Index.